How much funding has Otomagnetics raised?

Otomagnetics has disclosed $1.3M raised across 2 rounds.

Where is Otomagnetics headquartered?

Otomagnetics is headquartered in Rockville, US.

Otomagnetics

Rockville, US · Founded 2012 · Delaware corporation · 6 employees on LinkedIn

Otomagnetics develops a non-invasive magnetic injection system to deliver drugs and therapeutic payloads to the inner and middle ear, the eye, and the skin, aimed at treating conditions such as inner ear diseases. The technology has demonstrated drug delivery to the inner and middle ear in animal models without puncturing the eardrum.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

David BeylinNamed on SEC filing

Ting Pau OeiNamed on SEC filing

Benjamin ShapiroNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 2 rounds · 2017–2018

▶$1MraisedMar 2018 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Neela ChipalkattyDirector
Irving WeinbergDirector
David BeylinDirector
Benjamin ShapiroExecutive Officer, Director
Abhita BatraExecutive Officer, Director

Offering amount: $3.4M
Amount sold: $1M
Minimum investment: $1K
Proceeds to insiders: $250K
First sale: Mar 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$260KraisedJul 2017 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David BeylinExecutive Officer, Director
Ting Pau OeiExecutive Officer, Director
Benjamin ShapiroExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $260K
Minimum investment: $25K
Proceeds to insiders: $328K
First sale: Jul 2017
Incorporated: Limited Liability Company, Maryland
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

OtoNexus3 shared keywordsOtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type. The device targets pediatric otitis media diagnosis to support antibiotic stewardship and reduce misdiagnosis for physicians, hospitals, and payers.

Companies competing with Otomagnetics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Otomagnetics do?: Otomagnetics develops a non-invasive magnetic injection system to deliver drugs and therapeutic payloads to the inner and middle ear, the eye, and the skin, aimed at treating conditions such as inner ear diseases. The technology has demonstrated drug delivery to the inner and middle ear in animal models without puncturing the eardrum.
How much funding has Otomagnetics raised?: Otomagnetics has disclosed $1.3M raised across 2 rounds.
Where is Otomagnetics headquartered?: Otomagnetics is headquartered in Rockville, US.